Clinigen Acquires SSI Strategy as Pharma Services Add-on

Clinigen, a pharma services platform company backed by Triton Partners, acquired SSI Strategy, a drug development consultancy. The acquisition is described as part of Clinigen’s broader pharma services buildout, which includes prior purchases of pharma services companies such as Kinesys Consulting and Drug Safety Navigator.

The deal sits within a broader pattern of private equity expanding into pharma services, a sector spanning drug development through manufacturing, packaging, and commercialization. The article frames pharma services as a fragmented ecosystem where consolidation opportunities are attracting investors.